BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/23/2022 9:44:45 AM | Browse: 306 | Download: 885
 |
Received |
|
2022-06-18 07:06 |
|
Peer-Review Started |
|
2022-06-18 07:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-09-05 01:57 |
|
Revised |
|
2022-09-15 09:43 |
|
Second Decision |
|
2022-10-26 03:15 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-10-26 09:06 |
|
Articles in Press |
|
2022-10-26 09:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-10-21 22:23 |
|
Typeset the Manuscript |
|
2022-11-07 07:47 |
|
Publish the Manuscript Online |
|
2022-11-23 09:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiang-Yu Long, Shuang Zhang, Lian-Sha Tang, Xiang Li and Ji-Yan Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Key Research and Development Program of Guang’an, China |
2019ZYZF0121 |
|
| Corresponding Author |
Xiang-Yu Long, MA, Adjunct Associate Professor, Department of Oncology, Guang'an People’s Hospital, No. 1 Section 4, Binhe Road, Guang'an 638500, Sichuan Province, China. 371256871@qq.com |
| Key Words |
Conversion therapy; Immunotherapy; PD-1 blockade; HPV; Penile squamous cell carcinoma; Case report |
| Core Tip |
Locally advanced penile squamous cell carcinoma with bilateral inguinal lymph node metastases and extra-nodal extension does not respond well to surgical treatment alone, and the prognosis is very poor. In this study, the patient successfully completed inguinal lymph node dissection after conversion therapy of immunotherapy plus chemotherapy. This is the first patient with human papillomavirus 16+ unresectable locally advanced penile cancer treated with immunotherapy plus chemotherapy who eventually achieved a pathologically complete response. |
| Publish Date |
2022-11-23 09:44 |
| Citation |
Long XY, Zhang S, Tang LS, Li X, Liu JY. Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature. World J Clin Cases 2022; 10(33): 12305-12312 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i33/12305.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i33.12305 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
